253 related articles for article (PubMed ID: 28580709)
21. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
22. Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.
Daskalova SM; Radder JE; Cichacz ZA; Olsen SH; Tsaprailis G; Mason H; Lopez LC
BMC Biotechnol; 2010 Aug; 10():62. PubMed ID: 20735851
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
[TBL] [Abstract][Full Text] [Related]
24. A monoclonal IgM antibody to a methylcholanthrene-induced tumour. I. Specificity for alpha-N-acetylgalactosamine but with no cross-reactivity to the human blood group A determinant.
Gigliotti D; Teneberg S; Andersson R; Angström J; Karlsson KA; Wigzell H; Hansson M
Scand J Immunol; 1991 Apr; 33(4):345-55. PubMed ID: 1708163
[TBL] [Abstract][Full Text] [Related]
25. Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody.
Martínez-Sáez N; Castro-López J; Valero-González J; Madariaga D; Compañón I; Somovilla VJ; Salvadó M; Asensio JL; Jiménez-Barbero J; Avenoza A; Busto JH; Bernardes GJ; Peregrina JM; Hurtado-Guerrero R; Corzana F
Angew Chem Int Ed Engl; 2015 Aug; 54(34):9830-4. PubMed ID: 26118689
[TBL] [Abstract][Full Text] [Related]
26. The Tn antigen-structural simplicity and biological complexity.
Ju T; Otto VI; Cummings RD
Angew Chem Int Ed Engl; 2011 Feb; 50(8):1770-91. PubMed ID: 21259410
[TBL] [Abstract][Full Text] [Related]
27. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Freire T; Casaravilla C; Carmona C; Osinaga E
Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
[TBL] [Abstract][Full Text] [Related]
28. Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation.
Sanz-Martinez I; Pereira S; Merino P; Corzana F; Hurtado-Guerrero R
Acc Chem Res; 2023 Mar; 56(5):548-560. PubMed ID: 36815693
[TBL] [Abstract][Full Text] [Related]
29. In vitro synthesis of mucin-type O-glycans using saccharide primers comprising GalNAc-Ser and GalNAc-Thr residues.
Sakura R; Nagai K; Yagi Y; Takahashi Y; Ide Y; Yagi Y; Yamamoto D; Mizuno M; Sato T
Carbohydr Res; 2022 Jan; 511():108495. PubMed ID: 35026558
[TBL] [Abstract][Full Text] [Related]
30. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
31. N-acetylgalactosamine glycans function in cancer cell adhesion to endothelial cells: A role for truncated O-glycans in metastatic mechanisms.
Bapu D; Runions J; Kadhim M; Brooks SA
Cancer Lett; 2016 Jun; 375(2):367-374. PubMed ID: 26994652
[TBL] [Abstract][Full Text] [Related]
32. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
Springer GF; Desai PR
Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
[TBL] [Abstract][Full Text] [Related]
33. Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated Tn antigen.
Welinder C; Baldetorp B; Blixt O; Grabau D; Jansson B
PLoS One; 2013; 8(4):e61749. PubMed ID: 23637900
[TBL] [Abstract][Full Text] [Related]
34. Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells.
Persson N; Stuhr-Hansen N; Risinger C; Mereiter S; Polónia A; Polom K; Kovács A; Roviello F; Reis CA; Welinder C; Danielsson L; Jansson B; Blixt O
Glycobiology; 2017 Jul; 27(7):635-645. PubMed ID: 28419225
[TBL] [Abstract][Full Text] [Related]
35. The Cosmc connection to the Tn antigen in cancer.
Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
[TBL] [Abstract][Full Text] [Related]
36. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
[TBL] [Abstract][Full Text] [Related]
37. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
38. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
